Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.92M | 5.96M | -11.72M | -13.16M | -13.27M | -18.86M | -13.27M | -18.1M | -7.53M | -15.17M | -13.49M | -11.03M | -10.64M |
Depreciation & Amortization | 147K | 148K | 146K | 142K | 140K | 145K | 148K | 156K | 148K | 138K | 155K | 162K | 165K |
Stock-Based Compensation | 3.99M | 2.8M | 2.65M | 2.62M | 2.55M | 2.47M | 2.56M | 2.33M | 2.29M | 1.46M | 1.64M | 1.54M | 1.6M |
Other Working Capital | -7.46M | -29.56M | -4.85M | -6.39M | -8.86M | -4.8M | -6.79M | 402K | -14.77M | -7.5M | 41.51M | -5.56M | -5.42M |
Other Non-Cash Items | -2.75M | -2.56M | -2.08M | 19K | -1.7M | -1.32M | 75K | 214K | 445K | 583K | 67K | 74K | 72K |
Deferred Income Tax | n/a | 155K | n/a | -1.71M | n/a | 46K | 6K | 107K | n/a | -214K | 255K | 129K | 218K |
Change in Working Capital | -11.16M | -25.48M | -4.79M | -6.01M | -13.88M | 740K | -5.86M | -783K | 10.09M | -1.53M | 41.51M | -5.56M | -7.38M |
Operating Cash Flow | -27.69M | -18.97M | -15.8M | -18.09M | -26.15M | -16.79M | -16.35M | -16.07M | 5.45M | -14.73M | 30.13M | -14.68M | -15.97M |
Capital Expenditures | -19K | -114K | -1K | -279K | -93K | -116K | -55K | -215K | -26K | -49K | n/a | -30K | -39K |
Cash Acquisitions | n/a | 112.59M | 534K | -29.61M | -28.44M | 107.78M | -25.84M | -6.78M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -75.39M | -162.09M | -85.54M | -69.37M | -34.35M | -146.65M | -37.95M | -36.1M | -46.28M | -33.56M | -84.45M | -5.6M | -9.91M |
Sales Maturities Of Investments | 72.85M | 49.5M | 85M | 98.97M | 62.8M | 38.87M | 63.8M | 42.88M | 8.5M | 29.32M | 21.93M | 26.5M | 3.4M |
Other Investing Acitivies | n/a | -112.59M | -534K | 29.61M | 28.44M | -107.78M | 25.84M | 6.78M | -37.78M | -4.24M | -62.52M | 20.9M | -6.51M |
Investing Cash Flow | -2.56M | -112.7M | -535K | 29.33M | 28.35M | -107.9M | 25.79M | 6.56M | -37.8M | -4.29M | -62.52M | 20.87M | -6.55M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19.35M | 156.61M | 1.2M | 8.4M | -1.09M | 11.54M | 92.82M | -1.02M | -650K | 10.87M | 89.68M | 9K | 202K |
Financial Cash Flow | 19.35M | 156.61M | 1.2M | 8.4M | -1.09M | 11.54M | 92.82M | -1.02M | -650K | 10.87M | 89.68M | 9K | 202K |
Net Cash Flow | -10.9M | 24.94M | -15.1M | 19.61M | 1.09M | -113.25M | 102.27M | -10.53M | -33.02M | -8.19M | 57.29M | 6.18M | -22.33M |
Free Cash Flow | -27.71M | -19.09M | -15.8M | -18.37M | -26.25M | -16.9M | -16.4M | -16.28M | 5.42M | -14.78M | 30.13M | -14.71M | -16.01M |